FindTrial
Sign In

liposomal curcumin

DIETARY_SUPPLEMENT5 trials

Sponsors

SignPath Pharma, Inc., University of Hohenheim, University of Florida, S.LAB (SOLOWAYS), Erzincan Military Hospital

Conditions

Chronic Kidney Disease 5DDrug SafetyInflamatory Bowel DiseasePain ManagementPharmacokinetics After Oral IntakePostoperative CareSafety After Oral Intake

Phase 1

Evaluation of Liposomal Curcumin in Healthy Volunteers
CompletedNCT01403545
SignPath Pharma, Inc.Drug Safety
Start: 2011-08-31End: 2012-08-31Updated: 2014-05-26

Phase 3

High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.
CompletedNCT06381076
University of FloridaChronic Kidney Disease 5D
Start: 2025-02-03End: 2025-05-13Updated: 2026-07-22

Phase 4

Effectiveness of Curcuminoids in Controlling Postoperative Pain Following Total Laparoscopic Hysterectomy
CompletedNCT06886035
Erzincan Military HospitalPain Management, Postoperative Care
Start: 2025-03-21End: 2026-01-31Updated: 2026-04-02

Unknown Phase

Comparison of Curcumin Bioavailability
CompletedNCT03530436
University of HohenheimPharmacokinetics After Oral Intake, Safety After Oral Intake
Start: 2018-06-07End: 2018-11-07Updated: 2019-01-10
A Study of Curcumin (Soloways ™) in Patients With Inflammatory Bowel Disease Homozygous for the IL-10 Variant
CompletedNCT06867939
S.LAB (SOLOWAYS)Inflamatory Bowel Disease
Start: 2024-05-05End: 2025-02-02Updated: 2025-04-11
A Study of Curcumin (Soloways ™) in Patients With Inflammatory Bowel Disease Homozygous for the IL-10 Variant
CompletedNCT06867939
S.LAB (SOLOWAYS)Inflamatory Bowel Disease
Start: 2024-05-05End: 2025-02-02Updated: 2025-04-11